BACKGROUND: Umbilical cord blood (UCB) is a source of stem cells for allogeneic haematopoietic transplantation in paediatric and adult patients with haematological malignancies and other indications. Voluntary donation is the basis for the success of unrelated UCB transplantation programmes. In the last few years a growing number of private banks offer their services to expectant parents, to store UCB for future use. The debate concerning UCB donation and private preservation has been ongoing for several years. The aims of this single centre study were to explore knowledge about UCB stem cells and attitudes towards voluntary UCB donation or private UCB preservation among both blood donors and pregnant women. MATERIALS AND METHODS: This study was conducted at the "Sapienza" University of Rome. Two types of anonymous questionnaires were prepared: one type was administered to 1,000 blood donors while the other type was distributed to 300 pregnant women. RESULTS: Most blood donors as well as the majority of pregnant women had some general knowledge about UCB (89% and 93%, respectively) and were aware of the possibility of donating it (82% and 95%). However, the level of knowledge regarding current therapeutic use resulted generally low, only 91 (10%) among informed blood donors and 69 (31%) among informed pregnant women gave a correct answer. The survey revealed a preference for voluntary donation both among blood donors (76%) and among pregnant woman (55%). Indeed, a minority of blood donors (6.5%) and of pregnant women (9%) would opt to store UCB for private use. DISCUSSION: The study raises the following considerations: (i) the large support for UCB donation expressed by blood donors and by pregnant women suggests that UCB preservation does not represent an obstacle to the expansion of UCB donation and to development of unrelated transplantation programmes; (ii) information about UCB donation and preservation should be carefully given by professionals and institutions.
BACKGROUND: Umbilical cord blood (UCB) is a source of stem cells for allogeneic haematopoietic transplantation in paediatric and adult patients with haematological malignancies and other indications. Voluntary donation is the basis for the success of unrelated UCB transplantation programmes. In the last few years a growing number of private banks offer their services to expectant parents, to store UCB for future use. The debate concerning UCB donation and private preservation has been ongoing for several years. The aims of this single centre study were to explore knowledge about UCB stem cells and attitudes towards voluntary UCB donation or private UCB preservation among both blood donors and pregnant women. MATERIALS AND METHODS: This study was conducted at the "Sapienza" University of Rome. Two types of anonymous questionnaires were prepared: one type was administered to 1,000 blood donors while the other type was distributed to 300 pregnant women. RESULTS: Most blood donors as well as the majority of pregnant women had some general knowledge about UCB (89% and 93%, respectively) and were aware of the possibility of donating it (82% and 95%). However, the level of knowledge regarding current therapeutic use resulted generally low, only 91 (10%) among informed blood donors and 69 (31%) among informed pregnant women gave a correct answer. The survey revealed a preference for voluntary donation both among blood donors (76%) and among pregnant woman (55%). Indeed, a minority of blood donors (6.5%) and of pregnant women (9%) would opt to store UCB for private use. DISCUSSION: The study raises the following considerations: (i) the large support for UCB donation expressed by blood donors and by pregnant women suggests that UCB preservation does not represent an obstacle to the expansion of UCB donation and to development of unrelated transplantation programmes; (ii) information about UCB donation and preservation should be carefully given by professionals and institutions.
Authors: Joseph Rosenthal; Ann E Woolfrey; Anna Pawlowska; Sandra H Thomas; Frederick Appelbaum; Stephen Forman Journal: Pediatr Blood Cancer Date: 2011-03-02 Impact factor: 3.167
Authors: Gregory Katz; Antonia Mills; Joan Garcia; Karen Hooper; Colin McGuckin; Alexander Platz; Paolo Rebulla; Elena Salvaterra; Alexander H Schmidt; Marta Torrabadella Journal: Transfusion Date: 2010-12-03 Impact factor: 3.157
Authors: Stephen Sik Hung Suen; Terence T Lao; Oi Ka Chan; Thomas Kam On Kou; Sammy Chung Sum Chan; Jean Hee Kim; Tze Kin Lau; Tak Yeung Leung Journal: Acta Obstet Gynecol Scand Date: 2011-06-27 Impact factor: 3.636
Authors: Franco Locatelli; Vanderson Rocha; William Reed; Françoise Bernaudin; Mehmet Ertem; Stelios Grafakos; Benedicte Brichard; Xiaxin Li; Arnon Nagler; Giovanna Giorgiani; Paul R Haut; Joel A Brochstein; Diane J Nugent; Julie Blatt; Paul Woodard; Joanne Kurtzberg; Charles M Rubin; Roberto Miniero; Patrick Lutz; Thirumalairaj Raja; Irene Roberts; Andrew M Will; Isaac Yaniv; Christiane Vermylen; Nunzia Tannoia; Federico Garnier; Irina Ionescu; Mark C Walters; Bertram H Lubin; Eliane Gluckman Journal: Blood Date: 2002-11-07 Impact factor: 22.113
Authors: Louiza Z Karagiorgou; Maria-Nikoletta P Pantazopoulou; Nikolaos C Mainas; Apostolos I Beloukas; Anastasios G Kriebardis Journal: Blood Transfus Date: 2013-10-03 Impact factor: 3.443
Authors: H Hatzistilli; O Zissimopoulou; P Galanis; O Siskou; P Prezerakos; A Zissimopoulos; D Kaitelidou Journal: Hippokratia Date: 2014-04 Impact factor: 0.471